You are here: All Products  > Eccogene Signs $2 Billion Deal Selling Rights for GLP-1 Agonist to AstraZeneca

Eccogene Signs $2 Billion Deal Selling Rights for GLP-1 Agonist to AstraZeneca

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products